Dr Arjun Jain is the Managing Director and Chief Scientific Officer, ET-traps Limited, UK. He has a PhD in Reproductive Biochemistry from the University of Cambridge and has completed a Marie Curie
Postdoctoral Research Fellowship at the TransCure research Institute in Bern, Switzerland. Based on his research, he has designed the therapeutic tool that this project is based on. Based on his previous research, he has also designed experiments for the construction and testing of the ET-traps. He has done some ground breaking research in the field of endothelin-1 and is the first in the world to have created a soluble form of a G-protein coupled receptor (GPCR) in terms of its ligand binding ability. In this case, for endothelin-1, which has been termed ET-traps. For this, he has filed a patent.
Professor Johnson is a Fellow of Royal Society (FRS), Fellow of Academy of Medical Sciences (FMedSci), Fellow of Royal College of Obstetricians and Gynaocologists (FRCOG) and Fellow of the Royal Society of Biology (FRSB). He is an Emeritus Professor of Reproductive Sciences from the University of Cambridge, UK. He has co-authored over 300 papers on reproductive and development science, history, ethics, law and medical education over the course of his career.
Shaun Grady is a Vice President of Business Development Operations with AstraZeneca. He leads their transaction execution, due diligence and Alliance and Integration Management function including their late stage and on market licensing and partnering, M&A and divestments. His experience will be valuable in helping us commercialize ET-traps at the right point.
Ira has over 13 years of experience as a management consultant, working on market entry strategy, growth strategy, corporate restructuring and operations planning. She started her career with A.T Kearney after completing her MBA from the Indian Institute of Management Ahmedabad (IIMA) and her B.Computing (Hons) from the National University of Singapore. After working with A.T Kearney for 6+ years she decided to go freelance and was consulting for Aspire Advisors and various other clients in Hong Kong and Singapore. She is now working with ET-traps to support the business planning and strategy.
Ashok has 40 years of experience in the corporate sector, including COO of large organizations – AGIO Group, Russia and Charleston Holdings Singapore. He has worked across finance, operations & executions, risk management, coordination of new projects, sourcing and procurement of commodities and in banking. He has a P.G diploma in International Procurement from Export Institute Singapore, a certified associate from the Indian Institute of Bankers and a B.A (Hons.) Economics from the University of Delhi. Ashok has given several lectures on countertrade for seminars organized by the Export Institute of Singapore for industry professionals, senior business leaders and bankers.
Vidhi has over 9 years research experience working with Dabur Research Foundation and ET-traps Limited. She has a Master’s in Biotechnology from Amity Institute of Biotechnology. Vidhi has done a course on Writing in the Sciences (with Honors) and she, along with her teammates, completed the start-up accelerator programme established by Cambridge Judge Business School as part of the Biotech Start-up competition. While in Dabur’s drug discovery unit, Vidhi developed expertise in cell culture and maintenance, cytotoxicity profiling, determining properties of molecules and laying down SOPs for laboratory experiments, equipment and procedures and ensure their compliance.